03:27 AM EDT, 08/23/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on August 20, 2024, sold 15,000 shares in Alnylam Pharmaceuticals ( ALNY ) for $4,200,000. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 73,848 shares of the company, with 73,441 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000085/xslF345X05/edgardoc.xml

Price: 278.00, Change: +0.67, Percent Change: +0.24